https://www.fiercebiotech.com/biotech/regeneron-abandons-2seventybio-car-t-midway-through-phase-12-lymphoma-trial
Regeneron drops 2seventy CAR-T during ph. 1/2 lymphoma trial
Oct 23, 2025 - Regeneron has given up on a CAR-T candidate acquired from 2seventy last year before it finished a phase 1/2 lymphoma study.
car tregenerondrops
https://www.fool.ca/company/nasdaq-tsvt-2seventy-bio/374790/
2seventy Bio (NASDAQ:TSVT) Stock Price & News | The Motley Fool Canada
See the latest 2seventy Bio (NASDAQ:TSVT) stock price, company analysis, news, and price history from our investing experts.
the motley foolstock pricebionasdaq
https://robinhood.com/us/en/stocks/TSVT/
2seventy bio: TSVT Stock Price Quote & News | Robinhood
You can watch TSVT and buy and sell other stocks, ETFs, and their options commission-free on Robinhood. Change the date range, see whether others are buying or...
stock pricebioquotenewsrobinhood
https://public.com/stocks/tsvt/earnings
2Seventy Bio (TSVT) Earnings: Latest Report, Earnings Call & Financials
2Seventy Bio reported Beat earnings on May 7, 2025 with an EPS of $0.01 vs. -$0.10. View the full TSVT earnings report, listen to the earnings call, and...
latest reportbioearningscallfinancials